New REACH Rules Will Reduce Animal Use For Assessing Sensitization, Other Endpoints
This article was originally published in The Rose Sheet
Executive Summary
Alternative testing methods addressing key events in the OECD's adverse outcome pathway for skin sensitization may be sufficient to fulfill REACH data needs under a new rule slated for implementation later this year. Another pending change is expected to reduce firms' dependence on animal tests to evaluate skin and eye irritation and acute toxicity as the final REACH deadline for phase-in substances draws closer.
You may also be interested in...
EU Regulatory News In Brief: Non-Animal Test Guidance; REACH Enforcement Initiatives; More
The European Chemicals Agency provides updated guidance on using what are now default non-animal test methods under REACH for selected endpoints, including skin sensitization; meanwhile, EU authorities have kicked off inspections to assess how chemical hazard information is being communicated via safety data sheets to workers and other points in the supply chain. More European regulatory news in brief.
ECHA May Be Stickler In 2018 For ‘Last Resort’ Animal Tests Only
Requests for firms’ rationale behind animal tests and referrals to EU members states to investigate possible noncompliance may be more frequent under REACH going forward, following a European Ombudsman decision finding the European Chemicals Agency’s interpretation of its related duties “excessively restrictive.” PETA UK lodged a complaint in 2012 charging ECHA with maladministration of REACH, specifically the “last resort” principle for animal experimentation.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.